Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis
- First Posted Date
- 2020-07-08
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Pulmonary Research of Abingdon, LLC
- Target Recruit Count
- 50
- Registration Number
- NCT04461587
- Locations
- 🇺🇸
Pulmonary Research of Abingdon, LLC, Abingdon, Virginia, United States
News
No news found